VirTra Sets Third Quarter 2025 Conference Call for Monday, November 10, 2025 at 4:30 p.m. ET GlobeNewswire October 27, 2025 CHANDLER, Ariz., Oct. 27, 2025 (GLOBE NEWSWIRE) — VirTra, Inc. (Nasdaq: VTSI) (“VirTra” or the “Company”), a global provider of judgmental use-of-force and firearms training simulators, will hold a conference call on Monday, November 10, […]
Apyx Medical Corporation to Participate in Upcoming November Investor Conferences GlobeNewswire October 27, 2025 CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) — Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion(R) and the AYON Body Contouring System(TM), today announced that Charles
Absci to Participate in Upcoming Investor Conferences GlobeNewswire October 27, 2025 VANCOUVER, Wash. and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a clinical-stage biotech company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the following upcoming investor conferences: Guggenheim Securities 2nd Annual Healthcare Innovation
Pave Bank raises $39 million to scale world's first programmable bank built for digital assets and AI era Pave Bank announces fundraising led by Accel to expand its corporate and institutional bank offering that unifies traditional finance with regulated digital assets. GlobeNewswire October 27, 2025 Singapore, Oct. 27, 2025 (GLOBE NEWSWIRE) — The future of
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer GlobeNewswire October 27, 2025 Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record of strategic partnership deals Her more than 30 years of experience include leadership roles in the UK and US, from early
OXB to participate in upcoming investor conferences and events GlobeNewswire October 27, 2025 OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that members of its senior management team, including Dr. Frank Mathias, Chief
IN8bio Presents T cell Engager Data Demonstrating Deep B Cell Depletion for Autoimmune Indications GlobeNewswire October 27, 2025 INB-619 demonstrated equivalent efficacy to the FDA approved, commercial T Cell Engagers (TCE) compounds, blinatumomab and mosunetuzumab, with minimal adverse cytokine release, highlighting a targeted approach that potentially allows for safer deep B cell depletion. INB-619 is
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=174066&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
(NASDAQ:RECT), Expects to secure approximately SGD $2.3 million in energy storage equipment sales to Pansik within the next two months Expands business growth channels through strategic partnerships and market diversification Launches a new cooperation model with rental service providers, driving growing interest and collaboration from regional distributors in Thailand and neighboring markets SINGAPORE, Oct. 27,
Rectitude Holdings Partners with Pansik Technology Pte Ltd. to Drive Expansion in Renewable Energy Solutions GlobeNewswire October 27, 2025 Expects to secure approximately SGD $2.3 million in energy storage equipment sales to Pansik within the next two months Expands business growth channels through strategic partnerships and market diversification Launches a new cooperation model with rental